Rachelle W. Johnson - Concepedia

Author

Rachelle W. Johnson

Also Known As

Brun Nilsson, R Johnson, R W P Johnson, R. W. P. Johnson, R.W. Johnson, R.W.P. Johnson, Rachelle Johnson, Rachelle W Johnson, Rachelle W. Johnson, Rachelle W. Johnson

Publications

3.3K

Citations

H-Index

Concepts

All Affiliations

Vanderbilt University Vanderbilt University Medical Center St Vincents Institute of Medical Research The University of Melbourne VA Tennessee Valley Healthcare System

About

Rachelle W. Johnson is an author at Vanderbilt University specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	16	2.2K
2	Cell Biology	14	14	2K
3	Health Sciences	4	4	158
4	Engineering	2	2	67
5	Biomedical Engineering	1	1	33

Rachelle W. Johnson

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
Cell-programmed nutrient partitioning in the tumour microenvironment Bradley I. Reinfeld, Matthew Z. Madden, Melissa M. Wolf, Nature MedicineBiological MicroenvironmentsCell ProliferationCancer BiologyCell Biology	2021	942
Induction of LIFR confers a dormancy phenotype in breast cancer cells disseminated to the bone marrow Rachelle W. Johnson, Elizabeth Finger, Monica M. Olcina, Nature Cell Biology Lifr ConfersBreast OncologyDevelopmental BiologyLineage PlasticityCell Division	2016	265
TGF-β Promotion of Gli2-Induced Expression of Parathyroid Hormone-Related Protein, an Important Osteolytic Factor in Bone Metastasis, Is Independent of Canonical Hedgehog Signaling Rachelle W. Johnson, Mai P. Nguyen, Susan S. Padalecki, Cancer Research Pthrp InhibitionGli2-induced ExpressionCancer BiologyMammary Gland DevelopmentTumor Biology	2010	197
Myeloid-derived suppressor cells expand during breast cancer progression and promote tumor-induced bone destruction Sabrina Danilin, Alyssa R. Merkel, Joshua Johnson, OncoImmunology Breast OncologyBone Morphogenic ProteinMdscs ExpansionTumor GrowthMedicine	2012	131
The Primary Function of gp130 Signaling in Osteoblasts Is To Maintain Bone Formation and Strength, Rather Than Promote Osteoclast Formation Rachelle W. Johnson, Holly J. Brennan, Christina Vrahnas, Journal of Bone and Mineral Research SclerostinImmunologyOsteoporosisOsteoblasts IsMaintain Bone Formation	2013	107
Targeted Glycoproteomic Identification of Biomarkers for Human Breast Carcinoma Karen L. Abbott, Kazuhiro Aoki, Jae‐Min Lim, Journal of Proteome Research	2008	100
Anti-Transforming Growth Factor ß Antibody Treatment Rescues Bone Loss and Prevents Breast Cancer Metastasis to Bone Swati Biswas, Jeffry S. Nyman, JoAnn Alvarez, PLoS ONE Breast OncologyImmunologyTumor ImmunityCancer Cell BiologyBone Repair	2011	92
Longitudinal live animal micro-CT allows for quantitative analysis of tumor-induced bone destruction Lindsay C. Johnson, Rachelle W. Johnson, Steve Muñoz, Bone Bone ImagingMedical ImagingQuantitative AnalysisBiomedical ImagingBone Remodeling	2010	59
Glycoprotein130 (Gp130)/interleukin-6 (IL-6) signalling in osteoclasts promotes bone formation in periosteal and trabecular bone Rachelle W. Johnson, Narelle E. McGregor, Holly J. Brennan, Bone InflammationImmunologyOsteoclasts PromotesOsteoporosisBone Homeostasis	2015	58
Myokines (muscle-derived cytokines and chemokines) including ciliary neurotrophic factor (CNTF) inhibit osteoblast differentiation Rachelle W. Johnson, Jason D. White, Emma C. Walker, Bone InflammationInhibit Osteoblast DifferentiationCiliary Neurotrophic FactorBone Morphogenic ProteinImmunology	2014	57

Page 1